Last 12 months
Inside the activity.
0 purchase rows · 25 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 14 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 4 |
| Oct 2026 | 0 | 2 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 19, 2019 Filed Sep 23, 2019 22:02 UTC |
Hunt AnthonyDirector · Chief Executive Officer
|
SaleCommon Stock | 2,510 | $83.01 | $208,349.33 |
DisclosureSEC source: 0000899243-19-024058 · doc4.xml · nonDerivative · entry 3 Hunt Anthony · CIK 0001606030 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219,865 F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on September 21, 2018. F3 · price: $83.0077 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.48 to $83.43, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| September 19, 2019 Filed Sep 23, 2019 22:02 UTC |
Hunt AnthonyDirector · Chief Executive Officer
|
SaleCommon Stock | 638 | $81.82 | $52,198.23 |
DisclosureSEC source: 0000899243-19-024058 · doc4.xml · nonDerivative · entry 2 Hunt Anthony · CIK 0001606030 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 222,375 F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on September 21, 2018. F2 · price: $81.8154 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.315 to $82.305, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| September 19, 2019 Filed Sep 23, 2019 22:02 UTC |
Hunt AnthonyDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 20,000 | $16.55 | $331,000.00 |
DisclosureSEC source: 0000899243-19-024058 · doc4.xml · nonDerivative · entry 1 Hunt Anthony · CIK 0001606030 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 223,013 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 09, 2019 Filed Sep 11, 2019 20:58 UTC |
Hunt AnthonyDirector · Chief Executive Officer
|
SaleCommon Stock | 36 | $90.31 | $3,251.16 |
DisclosureSEC source: 0000899243-19-023324 · doc4.xml · nonDerivative · entry 7 Hunt Anthony · CIK 0001606030 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 203,013 F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on September 21, 2018. Read SEC document |
| September 09, 2019 Filed Sep 11, 2019 20:58 UTC |
Hunt AnthonyDirector · Chief Executive Officer
|
SaleCommon Stock | 288 | $89.27 | $25,709.59 |
DisclosureSEC source: 0000899243-19-023324 · doc4.xml · nonDerivative · entry 6 Hunt Anthony · CIK 0001606030 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 203,049 F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on September 21, 2018. F7 · price: $89.2694 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.26 to $89.29, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| September 09, 2019 Filed Sep 11, 2019 20:58 UTC |
Hunt AnthonyDirector · Chief Executive Officer
|
SaleCommon Stock | 222 | $86.26 | $19,149.63 |
DisclosureSEC source: 0000899243-19-023324 · doc4.xml · nonDerivative · entry 5 Hunt Anthony · CIK 0001606030 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 203,337 F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on September 21, 2018. F6 · price: $86.2596 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.985 to $86.465, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| September 09, 2019 Filed Sep 11, 2019 20:58 UTC |
Hunt AnthonyDirector · Chief Executive Officer
|
SaleCommon Stock | 740 | $84.64 | $62,631.97 |
DisclosureSEC source: 0000899243-19-023324 · doc4.xml · nonDerivative · entry 4 Hunt Anthony · CIK 0001606030 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 203,559 F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on September 21, 2018. F5 · price: $84.6378 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.095 to $85.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| September 09, 2019 Filed Sep 11, 2019 20:58 UTC |
Hunt AnthonyDirector · Chief Executive Officer
|
SaleCommon Stock | 1,751 | $83.05 | $145,418.97 |
DisclosureSEC source: 0000899243-19-023324 · doc4.xml · nonDerivative · entry 3 Hunt Anthony · CIK 0001606030 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 204,299 F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on September 21, 2018. F4 · price: $83.0491 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.655 to $83.485, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| September 09, 2019 Filed Sep 11, 2019 20:58 UTC |
Hunt AnthonyDirector · Chief Executive Officer
|
SaleCommon Stock | 4,926 | $82.15 | $404,683.71 |
DisclosureSEC source: 0000899243-19-023324 · doc4.xml · nonDerivative · entry 2 Hunt Anthony · CIK 0001606030 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 206,050 F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on September 21, 2018. F3 · price: $82.1526 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.645 to $82.615, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| September 09, 2019 Filed Sep 11, 2019 20:58 UTC |
Hunt AnthonyDirector · Chief Executive Officer
|
SaleCommon Stock | 4,131 | $81.26 | $335,675.97 |
DisclosureSEC source: 0000899243-19-023324 · doc4.xml · nonDerivative · entry 1 Hunt Anthony · CIK 0001606030 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,976 F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on September 21, 2018. F2 · price: $81.2578 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.645 to $81.64, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| July 15, 2019 Filed Jul 17, 2019 22:09 UTC |
Snodgres JonChief Financial Officer
|
Tax withholdingCommon Stock | 295 | $85.95 | $25,355.25 |
DisclosureSEC source: 0000899243-19-019788 · doc4.xml · nonDerivative · entry 1 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,239 F1 · shares: Payment of tax liability made via forfeiture of 295 shares of Common Stock valued at a price of $85.95 per share on July 15, 2019. Read SEC document |
| June 17, 2019 Filed Jun 19, 2019 23:00 UTC |
DAWES KAREN ADirector
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $4.96 | $0.00 |
DisclosureSEC source: 0000899243-19-017483 · doc4.xml · derivative · entry 3 DAWES KAREN A · CIK 0001261506 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2019-09-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option is currently exercisable. Read SEC document |
| June 17, 2019 Filed Jun 19, 2019 23:00 UTC |
DAWES KAREN ADirector
|
SaleCommon Stock | 1,295 | $77.35 | $100,168.25 |
DisclosureSEC source: 0000899243-19-017483 · doc4.xml · nonDerivative · entry 2 DAWES KAREN A · CIK 0001261506 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,034 F1 · kind: Sale of common stock to cover the exercise price and a portion of the tax liability resulting from the exercise of Ms. Dawes's stock options was allowed pursuant to an exception to a lock-up agreement, signed by Ms. Dawes on April 26, 2019 in connection with the public offering of the Company's common stock. F2 · price: $77.35 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.24 to $77.41, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| June 17, 2019 Filed Jun 19, 2019 23:00 UTC |
DAWES KAREN ADirector
|
Exercise / conversionCommon Stock | 20,000 | $4.96 | $99,200.00 |
DisclosureSEC source: 0000899243-19-017483 · doc4.xml · nonDerivative · entry 1 DAWES KAREN A · CIK 0001261506 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,329 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 23, 2019 Filed May 28, 2019 20:17 UTC |
COOPER GLENN L MDDirector
|
SaleCommon Stock | 266 | $67.53 | $17,962.98 |
DisclosureSEC source: 0000899243-19-014849 · doc4.xml · nonDerivative · entry 2 COOPER GLENN L MD · CIK 0001046351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,709 F1 · kind: Sale of common stock to cover the exercise price and a portion of the tax liability resulting from the exercise of Mr. Cooper's 24,000 stock options was allowed pursuant to an exception to a lock-up agreement, signed by Mr. Cooper on April 26, 2019 in connection with the public offering of the Company's common stock. F3 · price: $67.53 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.52 to $67.57, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| May 23, 2019 Filed May 28, 2019 20:17 UTC |
COOPER GLENN L MDDirector
|
SaleCommon Stock | 4,734 | $66.91 | $316,751.94 |
DisclosureSEC source: 0000899243-19-014849 · doc4.xml · nonDerivative · entry 1 COOPER GLENN L MD · CIK 0001046351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,975 F1 · kind: Sale of common stock to cover the exercise price and a portion of the tax liability resulting from the exercise of Mr. Cooper's 24,000 stock options was allowed pursuant to an exception to a lock-up agreement, signed by Mr. Cooper on April 26, 2019 in connection with the public offering of the Company's common stock. F2 · price: $66.91 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.42 to $67.36, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| May 23, 2019 Filed Jun 19, 2019 23:04 UTC Amendment |
COOPER GLENN L MDDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 24,000 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0000899243-19-017486 · doc4a.xml · derivative · entry 4 COOPER GLENN L MD · CIK 0001046351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 24,000 shares Expires 2019-08-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option is currently exercisable. Read SEC document |
| May 23, 2019 Filed Jun 19, 2019 23:04 UTC Amendment |
COOPER GLENN L MDDirector
|
SaleCommon Stock | 266 | $67.53 | $17,962.98 |
DisclosureSEC source: 0000899243-19-017486 · doc4a.xml · nonDerivative · entry 3 COOPER GLENN L MD · CIK 0001046351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,709 F1 · kind: Sale of common stock to cover the exercise price and a portion of the tax liability resulting from the exercise of Mr. Cooper's stock options was allowed pursuant to an exception to a lock-up agreement, signed by Mr. Cooper on April 26, 2019 in connection with the public offering of the Company's common stock. F3 · price: $67.53 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.52 to $67.57, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| May 23, 2019 Filed Jun 19, 2019 23:04 UTC Amendment |
COOPER GLENN L MDDirector
|
SaleCommon Stock | 4,734 | $66.91 | $316,751.94 |
DisclosureSEC source: 0000899243-19-017486 · doc4a.xml · nonDerivative · entry 2 COOPER GLENN L MD · CIK 0001046351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,975 F1 · kind: Sale of common stock to cover the exercise price and a portion of the tax liability resulting from the exercise of Mr. Cooper's stock options was allowed pursuant to an exception to a lock-up agreement, signed by Mr. Cooper on April 26, 2019 in connection with the public offering of the Company's common stock. F2 · price: $66.91 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.42 to $67.36, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| May 23, 2019 Filed Jun 19, 2019 23:04 UTC Amendment |
COOPER GLENN L MDDirector
|
Exercise / conversionCommon Stock | 24,000 | $5.00 | $120,000.00 |
DisclosureSEC source: 0000899243-19-017486 · doc4a.xml · nonDerivative · entry 1 COOPER GLENN L MD · CIK 0001046351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,709 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 15, 2019 Filed May 17, 2019 20:12 UTC |
RYAN THOMAS F JRDirector
|
GrantStock Option (Right to Buy) · Derivative | 2,109 | $0.00 Strike: $67.71 | $0.00 |
DisclosureSEC source: 0000899243-19-013995 · doc4.xml · derivative · entry 2 RYAN THOMAS F JR · CIK 0001263366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,109 Underlying: Common Stock · 2,109 shares Expires 2029-05-15 F2 · derivative.exercise_date: Award vests in full one year from grant date on May 15, 2020. Read SEC document |
| May 15, 2019 Filed May 17, 2019 20:12 UTC |
RYAN THOMAS F JRDirector
|
GrantCommon Stock | 923 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-013995 · doc4.xml · nonDerivative · entry 1 RYAN THOMAS F JR · CIK 0001263366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,148 F1 · shares: Mr. Ryan was awarded 923 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on May 15, 2020. The restricted stock units may be settled only be delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Read SEC document |
| May 15, 2019 Filed May 17, 2019 20:11 UTC |
Cox JohnDirector
|
GrantStock Option (Right to Buy) · Derivative | 2,109 | $0.00 Strike: $67.71 | $0.00 |
DisclosureSEC source: 0000899243-19-013994 · doc4.xml · derivative · entry 2 Cox John · CIK 0001498428 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,109 Underlying: Common Stock · 2,109 shares Expires 2029-05-15 F2 · derivative.exercise_date: Award vests in full one year from grant date on May 15, 2020. Read SEC document |
| May 15, 2019 Filed May 17, 2019 20:11 UTC |
Cox JohnDirector
|
GrantCommon Stock | 923 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-013994 · doc4.xml · nonDerivative · entry 1 Cox John · CIK 0001498428 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,236 F1 · shares: Mr. Cox was awarded 923 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on May 15, 2020. The restricted stock units may be settled only be delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Read SEC document |
| May 15, 2019 Filed May 17, 2019 20:11 UTC |
DAWES KAREN ADirector
|
GrantStock Option (Right to Buy) · Derivative | 2,953 | $0.00 Strike: $67.71 | $0.00 |
DisclosureSEC source: 0000899243-19-013993 · doc4.xml · derivative · entry 2 DAWES KAREN A · CIK 0001261506 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,953 Underlying: Common Stock · 2,953 shares Expires 2029-05-15 F2 · derivative.exercise_date: Award vests in full one year from grant date on May 15, 2020. Read SEC document |
| May 15, 2019 Filed May 17, 2019 20:11 UTC |
DAWES KAREN ADirector
|
GrantCommon Stock | 1,292 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-013993 · doc4.xml · nonDerivative · entry 1 DAWES KAREN A · CIK 0001261506 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,329 F1 · shares: Ms. Dawes was awarded 1,292 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on May 15, 2020. The restricted stock units may be settled only be delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Read SEC document |
| May 15, 2019 Filed May 17, 2019 20:10 UTC |
COOPER GLENN L MDDirector
|
GrantStock Option (Right to Buy) · Derivative | 2,109 | $0.00 Strike: $67.71 | $0.00 |
DisclosureSEC source: 0000899243-19-013992 · doc4.xml · derivative · entry 2 COOPER GLENN L MD · CIK 0001046351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,109 Underlying: Common Stock · 2,109 shares Expires 2029-05-15 F2 · derivative.exercise_date: Award vests in full one year from grant date on May 15, 2020. Read SEC document |
| May 15, 2019 Filed May 17, 2019 20:10 UTC |
COOPER GLENN L MDDirector
|
GrantCommon Stock | 923 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-013992 · doc4.xml · nonDerivative · entry 1 COOPER GLENN L MD · CIK 0001046351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,709 F1 · shares: Mr. Cooper was awarded 923 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on May 15, 2020. The restricted stock units may be settled only be delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Read SEC document |
| May 15, 2019 Filed May 17, 2019 20:10 UTC |
BARTHELEMY NICOLASDirector
|
GrantStock Option (Right to Buy) · Derivative | 2,109 | $0.00 Strike: $67.71 | $0.00 |
DisclosureSEC source: 0000899243-19-013991 · doc4.xml · derivative · entry 2 BARTHELEMY NICOLAS · CIK 0001283576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,109 Underlying: Common Stock · 2,109 shares Expires 2029-05-15 F2 · derivative.exercise_date: Award vests in full one year from grant date on May 15, 2020. Read SEC document |
| May 15, 2019 Filed May 17, 2019 20:10 UTC |
BARTHELEMY NICOLASDirector
|
GrantCommon Stock | 923 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-013991 · doc4.xml · nonDerivative · entry 1 BARTHELEMY NICOLAS · CIK 0001283576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,109 F1 · shares: Mr. Barthelemy was awarded 923 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on May 15, 2020. The restricted stock units may be settled only be delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Read SEC document |
| May 15, 2019 Filed May 17, 2019 20:10 UTC |
MUIR GLENN PDirector
|
GrantStock Option (Right to Buy) · Derivative | 2,109 | $0.00 Strike: $67.71 | $0.00 |
DisclosureSEC source: 0000899243-19-013990 · doc4.xml · derivative · entry 2 MUIR GLENN P · CIK 0001181190 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,109 Underlying: Common Stock · 2,109 shares Expires 2029-05-15 F2 · derivative.exercise_date: Award vests in full one year from grant date on May 15, 2020. Read SEC document |
| May 15, 2019 Filed May 17, 2019 20:10 UTC |
MUIR GLENN PDirector
|
GrantCommon Stock | 923 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-013990 · doc4.xml · nonDerivative · entry 1 MUIR GLENN P · CIK 0001181190 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,378 F1 · shares: Mr. Muir was awarded 923 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on May 15, 2020. The restricted stock units may be settled only be delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Read SEC document |
| May 13, 2019 Filed May 15, 2019 20:53 UTC |
KURIYEL RALFSenior VP, R&D
|
GrantCommon Stock | 8,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-013572 · doc4.xml · nonDerivative · entry 1 KURIYEL RALF · CIK 0001733143 · Senior VP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,803 F1 · shares: Mr. Kuriyel was awarded 8,000 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest in equal annual installments over a five-year period beginning on the first anniversary of the grant date. The restricted stock units may be settled only be delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Read SEC document |
| May 13, 2019 Filed May 15, 2019 20:50 UTC |
Snodgres JonChief Financial Officer
|
GrantCommon Stock | 8,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-013570 · doc4.xml · nonDerivative · entry 1 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,534 F1 · shares: Mr. Snodgres was awarded 8,000 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest in equal annual installments over a five-year period beginning on the first anniversary of the grant date. The restricted stock units may be settled only be delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance Read SEC document |
| March 25, 2019 Filed Mar 27, 2019 20:50 UTC |
Snodgres JonChief Financial Officer
|
SaleCommon Stock | 1,009 | $59.05 | $59,581.45 |
DisclosureSEC source: 0000899243-19-009025 · doc4.xml · nonDerivative · entry 2 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,534 F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on September 19, 2018. F3 · price: $59.05 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.90 to $59.40, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| March 25, 2019 Filed Mar 27, 2019 20:50 UTC |
Snodgres JonChief Financial Officer
|
SaleCommon Stock | 5,458 | $58.45 | $319,020.10 |
DisclosureSEC source: 0000899243-19-009025 · doc4.xml · nonDerivative · entry 1 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,543 F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on September 19, 2018. F2 · price: $58.45 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.90 to $58.86, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 12:20 UTC |
Hunt AnthonyDirector · Chief Executive Officer
|
SaleCommon Stock | 500 | $60.91 | $30,457.00 |
DisclosureSEC source: 0000899243-19-008472 · doc4.xml · nonDerivative · entry 3 Hunt Anthony · CIK 0001606030 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 215,107 F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on September 21, 2018. F4 · price: $60.9140 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.89 to $60.94, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 12:20 UTC |
Hunt AnthonyDirector · Chief Executive Officer
|
SaleCommon Stock | 4,009 | $60.45 | $242,362.89 |
DisclosureSEC source: 0000899243-19-008472 · doc4.xml · nonDerivative · entry 2 Hunt Anthony · CIK 0001606030 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 215,607 F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on September 21, 2018. F3 · price: $60.4547 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.87 to $60.85, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 12:20 UTC |
Hunt AnthonyDirector · Chief Executive Officer
|
SaleCommon Stock | 10,041 | $59.24 | $594,812.77 |
DisclosureSEC source: 0000899243-19-008472 · doc4.xml · nonDerivative · entry 1 Hunt Anthony · CIK 0001606030 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219,616 F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on September 21, 2018. F2 · price: $59.2384 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.87 to $59.835, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| March 05, 2019 Filed Mar 5, 2019 22:35 UTC |
Hunt AnthonyDirector · Chief Executive Officer
|
SaleCommon Stock | 13,000 | $58.50 | $760,500.00 |
DisclosureSEC source: 0000899243-19-006157 · doc4.xml · nonDerivative · entry 1 Hunt Anthony · CIK 0001606030 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 229,657 F1 · kind: Sale of 13,000 shares in the open market to cover tax liability resulting from the release of restricted stock units. F2 · price: $58.50 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.17 to $59.09, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| March 05, 2019 Filed Mar 5, 2019 22:34 UTC |
KURIYEL RALFSenior VP, R&D
|
SaleCommon Stock | 2,240 | $58.53 | $131,107.20 |
DisclosureSEC source: 0000899243-19-006156 · doc4.xml · nonDerivative · entry 2 KURIYEL RALF · CIK 0001733143 · Senior VP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,803 F2 · kind: Sale of 2,240 shares in the open market to cover tax liability resulting from the release of restricted stock units and PSUs. F3 · price: $58.53 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.30 to $58.89, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| March 05, 2019 Filed Mar 5, 2019 22:34 UTC |
Snodgres JonChief Financial Officer
|
SaleCommon Stock | 2,645 | $58.52 | $154,785.40 |
DisclosureSEC source: 0000899243-19-006155 · doc4.xml · nonDerivative · entry 2 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,001 F2 · kind: Sale of 2,645 shares in the open market to cover tax liability resulting from the release of restricted stock units and PSUs. F3 · price: $58.52 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.28 to $58.97, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 22:34 UTC |
KURIYEL RALFSenior VP, R&D
|
GrantCommon Stock | 4,700 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-006156 · doc4.xml · nonDerivative · entry 1 KURIYEL RALF · CIK 0001733143 · Senior VP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,043 F1 · shares: Represents shares awarded pursuant to Performance Share Units ("PSUs"). The Compensation Committee authorized the issuance of the underlying shares based upon the Issuer's achievement of pre-established performance criteria related to the filing of the 2018 Annual Report on Form 10-K, which was filed on March 1, 2019. These PSUs vested on March 1, 2019. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 22:34 UTC |
Snodgres JonChief Financial Officer
|
GrantCommon Stock | 4,700 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-006155 · doc4.xml · nonDerivative · entry 1 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,646 F1 · shares: Represents shares awarded pursuant to Performance Share Units ("PSUs"). The Compensation Committee authorized the issuance of the underlying shares based upon the Issuer's achievement of pre-established performance criteria related to the filing of the 2018 Annual Report on Form 10-K, which was filed on March 1, 2019. These PSUs vested on March 1, 2019. Read SEC document |
| February 28, 2019 Filed Mar 4, 2019 23:58 UTC |
Snodgres JonChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 5,653 | $0.00 Strike: $59.52 | $0.00 |
DisclosureSEC source: 0000899243-19-005889 · doc4.xml · derivative · entry 3 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,653 Underlying: Common Stock · 5,653 shares Expires 2029-02-28 F4 · derivative.exercise_date: One third of the stock options will vest and become exercisable annually on February 28, 2020, February 28, 2021 and February 28, 2022. Read SEC document |
| February 28, 2019 Filed Mar 4, 2019 23:58 UTC |
Snodgres JonChief Financial Officer
|
SaleCommon Stock | 1,875 | $58.88 | $110,400.00 |
DisclosureSEC source: 0000899243-19-005889 · doc4.xml · nonDerivative · entry 2 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,946 F2 · kind: Sale of 1,875 shares in the open market to cover tax liability resulting from the release of restricted stock units. F3 · price: $58.88 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.76 to $59.09 inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| February 28, 2019 Filed Mar 4, 2019 23:58 UTC |
Snodgres JonChief Financial Officer
|
GrantCommon Stock | 5,922 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-005889 · doc4.xml · nonDerivative · entry 1 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,821 F1 · shares: Mr. Snodgres was awarded 5,922 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest in equal annual installments over a three-year period beginning on the first anniversary of the grant date. The restricted stock units may be settled only be delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Read SEC document |
| February 28, 2019 Filed Mar 4, 2019 23:52 UTC |
Hunt AnthonyDirector · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 21,651 | $0.00 Strike: $59.52 | $0.00 |
DisclosureSEC source: 0000899243-19-005884 · doc4.xml · derivative · entry 3 Hunt Anthony · CIK 0001606030 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,651 Underlying: Common Stock · 21,651 shares Expires 2029-02-28 F4 · derivative.exercise_date: One third of the stock options will vest and become exercisable annually on February 28, 2020, February 28, 2021 and February 28, 2022. Read SEC document |
| February 28, 2019 Filed Mar 4, 2019 23:52 UTC |
Hunt AnthonyDirector · Chief Executive Officer
|
SaleCommon Stock | 7,475 | $59.01 | $441,099.75 |
DisclosureSEC source: 0000899243-19-005884 · doc4.xml · nonDerivative · entry 2 Hunt Anthony · CIK 0001606030 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 242,657 F2 · kind: Sale of 7,475 shares in the open market to cover tax liability resulting from the release of restricted stock units. F3 · price: $59.01 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.75 to $59.33, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| February 28, 2019 Filed Mar 4, 2019 23:52 UTC |
Hunt AnthonyDirector · Chief Executive Officer
|
GrantCommon Stock | 22,681 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-005884 · doc4.xml · nonDerivative · entry 1 Hunt Anthony · CIK 0001606030 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,132 F1 · shares: Mr. Hunt was awarded 22,681 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest in equal annual installments over a three-year period beginning on the first anniversary of the grant date. The restricted stock units may be settled only be delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.